ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Robert Young To Step Down As Fox Chase Cancer Center President in 2007.

September 29, 2006

UPCI Recruits Shin To Lead Head & Neck Cancer Program.

April 27, 2001

NCI Prepares For Intramural Program Review

June 27, 2014

Younger Patients, More Advanced Stages, More Likely To Die From Breast Cancer

September 24, 2004

Clinical Trials Approved By NCI

January 30, 2004

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997